GO
Loading...

Patents

More

  • Gov't office cracks down on working from home Tuesday, 18 Nov 2014 | 1:01 PM ET
    The U.S. Patent and Trademark Office (USPTO) seal is displayed outside the headquarters in Alexandria, Virginia.

    Patent examiners who work from home full time must abide by new rules, but critics in Congress questioned whether the policy was tough enough.

  • WASHINGTON, Nov 18- The U.S. Patent and Trademark Office has tightened supervision of patent examiners who work full-time from home, an official said on Tuesday, but critics in Congress questioned whether the office was not going far enough to curb abuse. The estimated 5,000 patent examiners who work from home full time must now be available electronically when...

  • The decision Friday by the U.S. Court of Appeals for the Federal Circuit invalidating the patent owned by Ultramercial LLC confirmed the reach of a recent U.S. Supreme Court ruling that has placed a cloud over the soundness of many software patents. CLS Bank, the Supreme Court ruled that a basic idea- not normally eligible for a patent- does not become...

  • *Nvidia sued Samsung, Qualcomm for patent infringement in Sept. SAN FRANCISCO, Nov 11- Samsung Electronics Co Ltd has accused Nvidia Corp of infringing several of its chip-related patents and for making false claims about its products, counter-suing after Nvidia filed a suit against the Korean company in September. Samsung's lawsuit came after Nvidia accused...

  • Samsung fires back at Nvidia with chip patents lawsuit Tuesday, 11 Nov 2014 | 8:40 PM ET

    SAN FRANCISCO, Nov 11- Samsung Electronics Co Ltd has accused Nvidia Corp of infringing several of its semiconductor-related patents and for making false claims about its products, counter-suing after Nvidia filed a lawsuit against the Korean company in September. The Asian electronics company also accuses Nvidia of false advertising when it says its "...

  • BERLIN, Nov 11- Germany and Britain will seek other countries' backing for a deal to ensure that tax breaks on profits generated from patented research apply only in the country where the research and innovation takes place. Germany has until now granted no "patent box" tax advantages and income from patents and licensed products is generally taxed, like...

  • BERLIN, Nov 11- Germany and Britain will seek other countries' backing for a deal to ensure that tax breaks on profits generated from patented research apply only in the country where the research and innovation takes place. Germany has until now granted no "patent box" tax advantages and income from patents and licensed products is generally taxed, like...

  • U.S. raises level of concern on Kuwait copyright laws Monday, 10 Nov 2014 | 10:45 AM ET

    WASHINGTON, Nov 10- The United States on Monday moved Kuwait a notch higher in its list of countries to watch for potential breaches of U.S. patents, copyrights and other intellectual property rights. Trade Representative said Kuwait had failed to introduce a copyright law in line with international standards and to properly protect copyright and trademarks.

  • WASHINGTON, Nov 6- The controversial patent assertion company MPHJ Technology Investments has reached an agreement with U.S. authorities barring it from using phony legal threats to demand patent licensing fees from small businesses, the Federal Trade Commission said on Thursday. "A patent is not a license to engage in deception," said Jessica Rich, director of...

  • WASHINGTON, Nov 6- The U.S. Federal Trade Commission has for the first time taken action against a patent assertion entity under its consumer protection authority, the agency said on Thursday. The FTC said MPHJ Technology Investments LLC had agreed to settle charges that they used deceptive sales claims and phony legal threats in letters that accused...

  • WASHINGTON, Nov 5- A Republican takeover of the U.S. Senate has brightened prospects for an effort to fight frivolous patent litigation, although the path to success is far from clear, sources close to the lobbying effort said on Wednesday. That legislation, backed by technology companies like Cisco Systems Inc and Google Inc, stalled in the Senate amid...

  • *Cipla says launched cheaper copy of Novartis drug in Delhi. *Cipla says Novartis not making enough drug for India. Cipla, India's fourth-largest drugmaker by revenue, said because there was an urgent but unmet need for the respiratory treatment in India it has started to sell a copy of the drug in Delhi priced at a fifth of the cost of Novartis's product.

  • Patent expirations weigh on Merck     Monday, 27 Oct 2014 | 9:31 AM ET

    The "Squawk on the Street" crew discusses pressures facing Merck in regards to drugs coming off patent, and the play on pharma companies.

  • U.S. court upholds patents on Pfizer's cancer drug Thursday, 23 Oct 2014 | 8:57 AM ET

    Oct 23- A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said. Pfizer filed the lawsuit in June 2010 after Mylan attempted to market a generic version of Sutent, patented until 2021.. The case is Pfizer Inc v.

  • INSIGHT-Big Tech winning battle with 'patent trolls' Wednesday, 22 Oct 2014 | 7:00 AM ET

    Oct 22- For two decades, companies that buy software patents to sue technology giants have been the scourge of Silicon Valley. Reviled as patent trolls, they have attacked everything from Google's online ads to Apple's iPhone features, sometimes winning hundreds of millions of dollars. NetApp, a Silicon Valley maker of sophisticated data storage devices, last...

  • Oct 17- A federal appeals court said it overturned a $15.4 million verdict against card payments company VeriFone Systems Inc because a lower court judge improperly interpreted the patents it had allegedly infringed. The U.S. Court of Appeals for the Federal Circuit on Friday said a jury in 2012 had wrongly concluded that VeriFone infringed the patents of...

  • Positive for Regeneron: Cramer     Friday, 17 Oct 2014 | 9:55 AM ET

    CNBC's Jim Cramer discusses news Regeneron's drug Eylea for treating diabetic macular edema created significantly greater improvement in visual acuity compared with Lucentis.

  • WASHINGTON, Oct 16- The White House on Thursday nominated Michelle Lee to be director of the U.S. Patent and Trademark Office, which the former executive with Internet giant Google Inc has led on an acting basis since January. Her nomination is subject to approval by the U.S. Senate.

  • Beats & Bose settle lawsuit: Report     Friday, 10 Oct 2014 | 3:28 PM ET

    Apple's Beats and Bose have settled their patent infringement dispute, reports CNBC's Julia Boorstin.

  • WASHINGTON, Oct 3- The acting head of the U.S. Patent and Trademark Office, former Google Inc executive Michelle Lee, is being seriously considered to permanently head the agency, sources have told Reuters. After leaving Google and before coming to the Virginia- based patent office, Lee headed the U.S. patent office's Silicon Valley outpost.